OpenAlex
Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance
Work
Year: 2023
Type: article
Abstract: High-dose isoniazid is recommended in the 9–12 months short-course regimen for multidrug-resistant tuberculosis with inhA mutation. However, there is insufficient evidence to support the assumption of... more
Cites: 29
Cited by: 3
Related to: 10
FWCI: 0.345
Citation percentile (by year/subfield): 47.9
Field: Medicine
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $1,720